Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV

Neurology

Volumn 48, Issue 1, 1997, Pages 13-18

  Harrison, L H ^a,e   Vaz, B ^b   Taveira, D M ^b   Quinn, T C ^a,c   Gibbs, C J ^d   De Souza, S H ^b   McArthur, J C ^a   Schechter, M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; PATHOGENESIS; PRIORITY JOURNAL; SPINAL CORD DISEASE;

EID: 0031016584     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.13     Document Type: Article

References (38)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77: 7415-7419.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982;79:2031-2035.
3. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol 1987;21:117-122.
4. Scientific Group. Report from the scientific group on HTLV-I infection and its associated diseases. Weekly Epidemiol Rec 1989;49:382-383.
5. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;312:874-879.
6. Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsybased case-control study. Neurology 1994;44:2159-2164.
7. Schechter M, Harrison LH, Halsey NA, et al. Co-infection with human T-cell lymphotropic virus type I and HIV in Brazil: impact on markers of HIV disease progression. JAMA 1994; 271:353-357.
8. Desormeaux J, Halsey N, Coberly J, et al. Absence of an association between HTLV-I, tuberculosis, and PPD size in HIV-I positive and HIV-I negative adults [abstract MC 3243]. Seventh International Conference on AIDS, Florence, 1991: 358.
9. Moreira ED, Ribeiro TT, Swanson P, et al. Seroepidemiology of human T-cell lymphotropic virus type I/II in Northeastern Brazil. J AIDS 1993;6:959-963.
10. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992;326:375-380.
11. Quinn TC, Zacarias FR, St. John RK. AIDS in the Americas: an emerging public health crisis. N Engl J Med 1989;320: 1005-1007.
12. Harrington WJ, Ucar A, Gill P, et al. Clinical spectrum of HTLV-I in South Florida. J AIDS 1995;8:466-473.
13. Manns A, Blattner WA. The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion 1991;31:67-75.
14. McArthur JC, Griffin JW, Cornblath DR, et al. Steroid-responsive myeloneuropathy in a man dually infected with HFV-1 and HTLV-I. Neurology 1990;40:938-944.
15. Beilke MA, Fazal BA, Lemos RS, Doulware DW. HAM/TSP and polymyositis in a man dually infected with HTLV-I and HIV-1. Proceedings of the Fifth International Conference on Human Retrovirology: HTLV. Kumamoto, Japan, May 11-13, 1992, Abstract P-38.
16. Aboulafia DM, Saxton EH, Koga H, Diagne A, Rosenblatt JD. A patient with progressive myelopathy and antibodies to human T-cell leukemia virus type I and human immunodeficiency virus type 1 in serum and cerebrospinal fluid. Arch Neurol 1990;47:477-479.
17. Brew BJ, Hardy W, Zuckerman E, et al. AIDS-related vacuolar myelopathy is not associated with coinfection by human T-lymphotropic virus type I. Ann Neurol 1989;26:679-681.
18. Berger JR, Raffanti S, Svenningsson A, McCarthy M, Snodgrass S, Resnick L. The role of HTLV in HIV-1 neurologic disease. Neurology 1991;41:197-202.
19. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322:383-388.
20. Jenks PJ, Barrett WY, Raftery MJ, et al. Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis 1995;21:992-993.
21. Lima LAA, May SB, Perez MA, Schechter M. Survival of HIV-1 infected Brazilian individuals: a model based on the WHO staging system. AIDS 1993;7:295-296.
22. World Health Organization. Interim proposal for a WHO staging system for HIV infection and disease. Weekly Epidemiol Rec 1990;65:221-228.
23. Kurtzke JF. A proposal for a uniform minimal record of disability in multiple sclerosis. Acta Neurol Scand 1981;64(S7): 110-129.
24. Lal RB, Heneine W, Rudolph DL, et al. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol 1991;29:2253-2258.
25. Larsen SA, Pope V, Quan T. Immunologic methods for the diagnosis of spirochetal diseases. In: Rose NR, DeMacario EC, Fahey J, Friedman H, Penn GM, eds. Manual of clinical laboratory immunology. 4th ed. Washington, DC: American Society for Microbiology, 1992:467-481.
26. McArthur JC, Cohen BA, Selnes OA, et al. Low prevalence of neurologic and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the Multi-center AIDS Cohort Study. Ann Neurol 1989;26:601-611.
27. Smith T, Jakobsen J, Trojaborg W. Myelopathy and HIV infection. AIDS 1990;4:589-591.
28. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-785.
29. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990;96:103-123.
30. Höllsberg P, Hafler DA. What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis? Ann Neurol 1995;37:143-145.
31. Nascimento OJM, Araújo AQ-C, Freitas MRG, Escada TM, Andrada-Serpa MJ. Peripheral nerve involvement in HTLV-I associated myelopathy [abstract]. J Acquir Immune Defic Syndr 1995;10:230.
32. Said G, Goulon-Goeau C, Lacroix C, Fève A, Descamps H, Fouchard M. Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I-associated myelopathy. Ann Neurol 1988;24:275-277.
33. Sugimura K, Takahashi A, Watanabe M, Mano K, Watanabe H. Demyelinating changes in sural nerve biopsy of patients with HTLV-I-associated myelopathy. Neurology 1990;40: 1263-1266.
34. Zehender G, De Maddalena C, Osio M, et al. High prevalence of human T-cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type !-associated predominantly sensory polyneuropathy. J Infect Dis 1995;172:1595-1598.
35. Royal W, Updike M, Selnes OA, et al. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991;41:1905-1910.
36. Wiktor SZ, Cannon RO, Atkinson WL, et al. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis 1992;165:920-924.
37. Osame M, Igata A, Matsumoto M, Kohka M, Usuku K, Izumo S. HTLV-I associated myelopathy (HAM): treatment trials, retrospective survey and clinical and laboratory findings. Hematol Rev 1990;3:271-284.
38. Osame M, Igata A, Matsumoto M. HTLV-I associated myelopathy revisited. In: Roman G, Vernant JC, Osame M, eds. HTLV-I and the nervous system: neurology and biology. New York: Alan R. Liss, 1989;51:213-223.